血清Aβ1-42、Bcl-2预测老年人认知功能障碍进展为阿尔茨海默病的价值

doi:10.3969/j.issn.1003-9198.2024.06.010

摘要/Abstract

摘要： 目的探究血清β-淀粉样蛋白1-42(Aβ1-42)、B淋巴细胞瘤因子-2(Bcl-2)水平预测老年认知功能障碍病人AD发病的价值。方法回顾性选取徐州医科大学附属医院2017—2019年收治的141例老年认知功能障碍病人。收集病人入院时血清Aβ1-42、Bcl-2水平。随访3年,记录病人AD发生情况,将其分为AD组和无AD组,比较2组病人临床相关资料,分析病人发生AD的影响因素;用ROC曲线分析Aβ1-42、Bcl-2对老年认知功能障碍病人AD发病的预测价值。结果 141例病人中失访24例,有效随访的117例病人中AD发生率为24.79%(29/117)。AD组Aβ1-42水平高于无AD组,Bcl-2水平低于无AD组(P＜0.01)。2组性别、BMI、合并高血压和冠心病、高血脂、婚姻状况、照顾者、吸烟情况比较,差异均无统计学意义(P＞0.05);AD组年龄、合并糖尿病比例、文化程度为初中及以下比例高于无AD组,MoCA评分低于无AD组(P＜0.05)。二元Logistic回归分析结果显示,年龄(OR=3.614)、Aβ1-42水平(OR=4.823)是病人发生AD的危险因素,Bcl-2水平(OR=0.311)是保护因素(P＜0.05)。ROC曲线显示,Aβ1-42、Bcl-2及二者联合预测老年认知功能障碍病人发生AD的敏感度分别为75.90%、65.50%、89.70%,特异度分别为71.60%、72.70%、90.90%,AUC分别为0.784、0.729、0.920。结论血清Aβ1-42水平是影响老年认知功能障碍病人发生AD的危险因素,血清Bcl-2水平为保护因素,通过检测Aβ1-42、Bcl-2水平可有效预测病人进展为AD的风险,且二者联合预测价值更好。

关键词: 老年人, 认知功能障碍, 阿尔茨海默病, β-淀粉样蛋白1-42, B淋巴细胞瘤因子-2, 预测价值

Abstract: Objective To investigate the preditive value of serum levels of β-amyloid protein 1-42 (Aβ1-42) and B-cell lymphoma factor-2 (Bcl-2) in the pathogenesis of Alzheimer’s disease (AD) in the elderly patients with cognitive impairment. Methods A total of 141 elderly patients with cognitive impairment admitted to the Affiliated Hospital of Xuzhou Medical University from 2017 to 2019 were retrospectively enrolled in the study. The patients were followed up for 3 years to observe the occurrence of AD, and were divided into AD group and non-AD group. The clinical data of the two groups were compared. Multivariate analysis was used to analyze the influencing factors of AD. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of Aβ1-42 and Bcl-2 for the occurrence of AD in the elderly patients with cognitive impairment. Results Among 141 patients, 24 patients were lost to follow-up. The incidence rate of AD in 117 patients with effective follow-up was 24.79% (29/117). The level of Aβ1-42 was significantly higher and the level of Bcl-2 was significantly lower in AD group than that in non-AD group (P<0.01). There were no significant differences in gender, body mass index, hypertension, coronary heart disease, hyperlipidemia, marital status, caregivers and smoking between the two groups (P>0.05). Compared with non-AD group, AD group had higher age, higher proportion of patients with diabetes, higher proportion of patients with an education level of junior high school or below, and a lower Montreal Cognitive Assessment (MoCA) score (P<0.05). Binary Logistic regression analysis showed that age (OR=3.614) and Aβ1-42 (OR=4.823) were risk factors for AD, while Bcl-2 (OR=0.311) was a protective factor (P<0.05). ROC curve showed that the sensitivity of Aβ1-42, Bcl-2 and their combination to predict AD in the elderly patients with cognitive impairment was 75.90%, 65.50% and 89.70%, respectively, and the specificity was 71.60%, 72.70% and 90.90%, respectively. The area under the curve (AUC) was 0.784, 0.729 and 0.920, respectively. Conclusions The serum level of Aβ1-42 is a risk factor for AD in the elderly patients with cognitive impairment, and the serum level of Bcl-2 is a protective factor. The detection of Aβ1-42 and Bcl-2 can effectively predict the occurrence of AD in the elderly patients with cognitive impairment, and the combination of the two indexes has a better predictive value.

Key words: aged, cognitive impairment, Alzheimer’s disease, β-amyloid 1-42, B-cell lymphoma factor-2, predictive value

中图分类号:

R749.17

刘田, 杨荣礼, 韩慧萍. 血清Aβ1-42、Bcl-2预测老年人认知功能障碍进展为阿尔茨海默病的价值[J]. 实用老年医学, 2024, 38(6): 582-586.

LIU Tian, YANG Rongli, HAN Huiping. Value of serum levels of Aβ1-42 and Bcl-2 in predicting the pathogenesis of Alzheimer’s disease in elderly patients with cognitive impairment[J]. Practical Geriatrics, 2024, 38(6): 582-586.

参考文献

[1] LI H F J, KNIGHT W C, XU J B, et al. Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases[J]. Neural Regen Res, 2022,17(4):867-874.
[2] AHMED H A, ISHRAT T. Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease[J]. Neural Regen Res, 2022,17(5):1018-1019.
[3] GONZÁLEZ D A, RESCH Z J, GONZALES M M, et al. A novel method for establishing functional change in older adults with cognitive impairment[J]. Alzheimer Dis Assoc Disord, 2022,36(3):238-243.
[4] 寿飞燕, 吴承龙, 傅丹旦, 等. 生慧汤加味联合多奈哌齐治疗老年轻度认知功能障碍肾精亏虚证临床研究[J]. 新中医, 2022,54(10):58-60.
[5] MAO L, CHEN X H, ZHUANG J H, et al. Relationship between β-amyloid protein 1-42, thyroid hormone levels and the risk of cognitive impairment after ischemic stroke[J]. World J Clin Cases, 2020,8(1):76-87.
[6] SUELVES N, SALEKI S, IBRAHIM T, et al. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology[J]. Acta Neuropathol Commun, 2023,11(1):82.
[7] SUROTO H, ASRIEL A, VEGA B D, et al. Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury[J]. J Musculoskelet Neuronal Interact, 2021,21(4):528-532.
[8] PETERSEN R C, NEGASH S. Mild cognitive impairment: an overview[J]. CNS Spectr, 2008,13(1):45-53.
[9] NASREDDINE Z S, PHILLIPS N A, BÉDIRIAN V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005,53(4):695-699.
[10] 贾建平, 邢怡, 武力勇, 等. 阿尔茨海默病诊疗指南[J]. 浙江医学, 2014, 36(13):1127-1128.
[11] WON J, CALLOW D D, PENA G S, et al. Hippocampal functional connectivity and memory performance after exercise intervention in older adults with mild cognitive impairment[J]. J Alzheimers Dis, 2021,82(3):1015-1031.
[12] 艾伟平, 向春晨, 张玉梅. 脑脊液神经颗粒素水平对阿尔茨海默病从轻度认知障碍进展为痴呆的预测价值分析[J]. 中国医刊, 2022,57(9):1003-1006.
[13] 林哲, 宋晓鼎, 曾永婷. 血清缓激肽与同型半胱氨酸用于预测老年轻度认知功能障碍患者进展为阿尔茨海默病的临床价值[J]. 中国老年学杂志, 2019,39(17):4278-4280.
[14] 王玲玲, 杨娟, 王涛, 等. 甘露特纳胶囊改善阿尔兹海默病认知障碍并降低神经炎症的机制研究[J]. 河北医科大学学报, 2023,44(6):629-634,639.
[15] SOM S, ANTONY J, DHANABAL S, et al. Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1-42) induced neurotoxicity in animal model of Alzheimer’s disease[J]. Metab Brain Dis, 2022,37(2):359-372.
[16] 谭丽, 唐铭, 高慧娟, 等. 龟龄集治疗老年轻-中度认知功能障碍肾虚髓减证的随机双盲对照研究[J]. 现代中西医结合杂志, 2022,31(24):3392-3397.
[17] 胡善明, 王亚楠, 许正茂, 等. Bcl-2家族分子在细胞凋亡中的作用研究进展[J]. 动物医学进展, 2021,42(10):85-89.
[18] LU S Y, WEI X J, ZHANG H L, et al. Protective effect of 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione, isolated from Averrhoa carambola L., against Aβ1-42-induced apoptosis in SH-SY5Y cells by reversing Bcl-2/Bax ratio[J]. Psychopharmacology:Berl, 2021,238(1):193-200.
[19] 王海岭, 姚丰菊, 郭正军, 等. 河南省65岁及以上老年人群阿尔兹海默病现状及影响因素[J]. 现代预防医学, 2022,49(8):1356-1360,1369.
[20] 汪睿彤, 刘珏. 2型糖尿病与阿尔兹海默病相关性的研究进展[J]. 现代预防医学, 2021,48(1):182-185.
[21] 李文晶, 李建英, 亓林青, 等. 阿尔兹海默病与轻度认知功能障碍的关系[J]. 实用心脑肺血管病杂志, 2019,27(s1):240-242.
[22] CHANG K H, HUANG C C, CHEN C M, et al. Differences in clinical presentation of behavioral and psychological symptoms of dementia in Alzheimer’s disease according to sex and education level[J]. J Alzheimers Dis, 2020,78(2):711-719.